{"id":"treatment-simplification","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach aims to improve medication adherence and quality of life in HIV patients by decreasing pill burden and dosing frequency. Simplified regimens typically combine multiple antiretroviral agents into single-tablet or dual-tablet formulations, maintaining therapeutic efficacy while enhancing patient convenience and compliance.","oneSentence":"Treatment simplification refers to reducing the complexity of antiretroviral regimens by consolidating multiple drugs into fewer, more convenient formulations.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:14:12.384Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection (treatment simplification strategy)"}]},"trialDetails":[{"nctId":"NCT07489547","phase":"PHASE2, PHASE3","title":"Medication Withdrawal in Stable HF With Improved LVEF","status":"RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2025-03-01","conditions":"Heart Failure","enrollment":90},{"nctId":"NCT04283409","phase":"NA","title":"Which Exercise for Low Back Pain? Predicting Response to Exercise for Patients With Low Back Pain","status":"COMPLETED","sponsor":"McMaster University","startDate":"2020-09-15","conditions":"Non-specific Low Back Pain","enrollment":425},{"nctId":"NCT04464746","phase":"NA","title":"Therapeutic Adherence in Uncontrolled Arterial Hypertension","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2018-07-01","conditions":"Treatment Adherence","enrollment":47},{"nctId":"NCT03333083","phase":"PHASE3","title":"Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen","status":"TERMINATED","sponsor":"Judit Pich","startDate":"2018-05-03","conditions":"HIV Seropositivity, HIV Infections, HIV-1-infection","enrollment":17},{"nctId":"NCT05707923","phase":"NA","title":"How Simplified Language Affects Comprehension and Learning in Young Autistic Children","status":"RECRUITING","sponsor":"Michigan State University","startDate":"2023-06-01","conditions":"Autism Spectrum Disorder","enrollment":104},{"nctId":"NCT04034862","phase":"PHASE3","title":"Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs","status":"COMPLETED","sponsor":"University of Liege","startDate":"2019-10-01","conditions":"HIV Infections","enrollment":36},{"nctId":"NCT03501719","phase":"","title":"Effects of ART Simplification on Inflammatory Markers in CoRis (AIR)","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2018-03-01","conditions":"HIV","enrollment":177},{"nctId":"NCT05254509","phase":"NA","title":"Virtual Reality, Debriefing and Chronic Pain","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2022-04-18","conditions":"Chronic Pain","enrollment":32},{"nctId":"NCT05433987","phase":"","title":"Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy","status":"COMPLETED","sponsor":"Centre Hospitalier de Cannes Simone Veil","startDate":"2022-07-28","conditions":"HIV-1-infection","enrollment":20},{"nctId":"NCT06341322","phase":"NA","title":"Using Behavioural and Cultural Insights to Increase Colorectal Cancer Home-testing in Croatia","status":"RECRUITING","sponsor":"Veerle Snijders","startDate":"2024-03-05","conditions":"Colorectal Cancer, Behavior Change","enrollment":13000},{"nctId":"NCT01511809","phase":"PHASE3","title":"Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression","status":"COMPLETED","sponsor":"IRCCS San Raffaele","startDate":"2010-09","conditions":"HIV-1 Infection","enrollment":117},{"nctId":"NCT05402566","phase":"","title":"MRI Assessment of Impaired Glucose Metabolism in Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2022-12-22","conditions":"Alzheimer Disease","enrollment":21},{"nctId":"NCT05906459","phase":"","title":"Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform\" in China(STAT)","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2023-06-26","conditions":"Hepatitis C Virus Infection","enrollment":20000},{"nctId":"NCT04618029","phase":"NA","title":"Feasibility of a Home Hazard Management Program for Malaysian Stroke Survivors","status":"COMPLETED","sponsor":"Universiti Putra Malaysia","startDate":"2021-01-01","conditions":"Stroke","enrollment":30},{"nctId":"NCT03958591","phase":"PHASE4","title":"Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification","status":"UNKNOWN","sponsor":"Yanbing Li","startDate":"2019-05-01","conditions":"Diabetes type2","enrollment":274},{"nctId":"NCT03683524","phase":"PHASE4","title":"EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS","status":"COMPLETED","sponsor":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","startDate":"2018-11-19","conditions":"HIV-1 Infection","enrollment":96},{"nctId":"NCT00084019","phase":"NA","title":"Atazanavir/Ritonavir Maintenance Therapy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-07","conditions":"HIV Infections","enrollment":36},{"nctId":"NCT03447873","phase":"PHASE4","title":"Tripe Versus Dual Antiretroviral Therapy in HIV-infected Patients With Virological Suppression (Tridual)","status":"COMPLETED","sponsor":"Hospitales Universitarios Virgen del Rocío","startDate":"2017-06-01","conditions":"HIV Infections","enrollment":153},{"nctId":"NCT02022111","phase":"NA","title":"INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) Study","status":"COMPLETED","sponsor":"Emory University","startDate":"2014-03","conditions":"Diabetes, Depression, Cardiovascular Risk Factor","enrollment":404},{"nctId":"NCT04766593","phase":"NA","title":"Effects of a Specific Programme for the Recovery of Autonomy Plus Multimodal Physical Exercise in Oncology Patients With Dyspnoea","status":"UNKNOWN","sponsor":"University of Salamanca","startDate":"2021-05-01","conditions":"Cancer, Dyspnea","enrollment":50},{"nctId":"NCT03549312","phase":"PHASE4","title":"Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy","status":"UNKNOWN","sponsor":"Saskatchewan Health Authority - Regina Area","startDate":"2018-02-01","conditions":"HIV-1-infection, Hepatitis C, Chronic, Methadone Dependence","enrollment":25},{"nctId":"NCT00611039","phase":"PHASE4","title":"Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2008-02","conditions":"HIV Infections","enrollment":30},{"nctId":"NCT01892579","phase":"NA","title":"Reducing Agitation in People With Dementia: the Customized Activity Trial","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2013-11","conditions":"Dementia","enrollment":250},{"nctId":"NCT03327753","phase":"NA","title":"Which Exercise for Low Back Pain: A Validation Study","status":"COMPLETED","sponsor":"McMaster University","startDate":"2017-01-10","conditions":"Chronic Low Back Pain, Non Specific Low Back Pain","enrollment":20},{"nctId":"NCT02199613","phase":"PHASE4","title":"Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2014-10","conditions":"HIV Infection","enrollment":10},{"nctId":"NCT01581853","phase":"PHASE4","title":"Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily","status":"COMPLETED","sponsor":"Daniel Podzamczer","startDate":"2012-05","conditions":"HIV","enrollment":21},{"nctId":"NCT01127204","phase":"PHASE2, PHASE3","title":"Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2011-06","conditions":"HIV Infections","enrollment":161},{"nctId":"NCT01367210","phase":"PHASE4","title":"Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)","status":"TERMINATED","sponsor":"Catholic University of the Sacred Heart","startDate":"2011-06","conditions":"HIV Infection","enrollment":165},{"nctId":"NCT02157311","phase":"PHASE3","title":"4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2014-07","conditions":"HIV-1 Infection","enrollment":100},{"nctId":"NCT01291459","phase":"PHASE2","title":"Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients","status":"UNKNOWN","sponsor":"Association Pour la Recherche en Infectiologie","startDate":"2011-09","conditions":"HIV","enrollment":40},{"nctId":"NCT00159224","phase":"PHASE4","title":"Induction-maintenance of Lopinavir/r in HIV-infected Subjects","status":"COMPLETED","sponsor":"Fundación Huésped","startDate":"2005-04","conditions":"HIV Infections","enrollment":100},{"nctId":"NCT01307488","phase":"PHASE4","title":"Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy","status":"COMPLETED","sponsor":"Fundacion SEIMC-GESIDA","startDate":"2011-09","conditions":"HIV Infection","enrollment":286},{"nctId":"NCT00885482","phase":"PHASE4","title":"Atazanavir and Lamivudine for Treatment Simplification","status":"COMPLETED","sponsor":"Catholic University of the Sacred Heart","startDate":"2009-05","conditions":"HIV Infections","enrollment":40},{"nctId":"NCT00958100","phase":"PHASE2","title":"Raltegravir Switch for Toxicity or Adverse Events","status":"COMPLETED","sponsor":"Catholic University of the Sacred Heart","startDate":"2009-08","conditions":"HIV/AIDS, Antiretroviral Therapy, HIV Infections","enrollment":40},{"nctId":"NCT01471821","phase":"PHASE4","title":"Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression","status":"COMPLETED","sponsor":"Juan A. Arnaiz","startDate":"2011-10","conditions":"HIV Infection","enrollment":250},{"nctId":"NCT02199353","phase":"NA","title":"Occupational Therapy Programme of Patients With Dementia Performing Activities of Daily Living","status":"COMPLETED","sponsor":"University of Extremadura","startDate":"2012-11","conditions":"Dementia","enrollment":58},{"nctId":"NCT00994344","phase":"PHASE4","title":"Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2009-10","conditions":"HIV Infections","enrollment":73},{"nctId":"NCT01102972","phase":"PHASE4","title":"A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2010-04","conditions":"Infection, Human Immunodeficiency Virus","enrollment":297},{"nctId":"NCT00140751","phase":"PHASE3","title":"Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients","status":"COMPLETED","sponsor":"Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba","startDate":"2005-10","conditions":"HIV Infections","enrollment":186},{"nctId":"NCT01391013","phase":"PHASE2","title":"A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients","status":"COMPLETED","sponsor":"Janssen-Cilag S.p.A.","startDate":"2009-06","conditions":"Human Immunodeficiency Virus 1","enrollment":30},{"nctId":"NCT00458302","phase":"PHASE3","title":"Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2007-06","conditions":"HIV Infections, AIDS Virus, Human Immunodeficiency Virus","enrollment":256},{"nctId":"NCT00440947","phase":"PHASE3","title":"Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2007-03","conditions":"Infection, Human Immunodeficiency Virus I, HIV Infection","enrollment":515},{"nctId":"NCT00941083","phase":"PHASE4","title":"Simplification From Protease Inhibitors to Raltegravir","status":"UNKNOWN","sponsor":"Hospital Carlos III, Madrid","startDate":"2009-01","conditions":"HIV Infections","enrollment":240},{"nctId":"NCT00318123","phase":"PHASE3","title":"Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2004-04","conditions":"HIV Infections","enrollment":126},{"nctId":"NCT00314626","phase":"PHASE3","title":"Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2004-11","conditions":"HIV Infections","enrollment":99},{"nctId":"NCT00158457","phase":"PHASE3","title":"Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)","status":"COMPLETED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2004-06","conditions":"HIV Infection","enrollment":40},{"nctId":"NCT00196612","phase":"PHASE3","title":"Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART","status":"COMPLETED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2001-04","conditions":"HIV Infections","enrollment":350}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":181,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Darunavir 800mg plus Stribild tablet once daily"],"phase":"marketed","status":"active","brandName":"Treatment simplification","genericName":"Treatment simplification","companyName":"University of British Columbia","companyId":"university-of-british-columbia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Treatment simplification refers to reducing the complexity of antiretroviral regimens by consolidating multiple drugs into fewer, more convenient formulations. Used for HIV-1 infection (treatment simplification strategy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}